Sethi AA - Search Results

1

Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease.

Sethi AA, Nordestgaard BG, Grønholdt ML, Steffensen R, Jensen G, Tybjaerg-Hansen A. Sethi AA, et al. Hypertension. 2003 Jun;41(6):1202-11. doi: 10.1161/01.HYP.0000072334.34433.17. Epub 2003 May 12. Hypertension. 2003. PMID: 12743009

2

Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis.

Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Sethi AA, et al. Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1269-75. doi: 10.1161/01.ATV.0000079007.40884.5C. Epub 2003 Jun 12. Arterioscler Thromb Vasc Biol. 2003. PMID: 12805070

3

164Ile allele in the beta2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study.

Sethi AA, Tybjaerg-Hansen A, Jensen GB, Nordestgaard BG. Sethi AA, et al. Pharmacogenet Genomics. 2005 Sep;15(9):633-45. doi: 10.1097/01.fpc.0000172243.27299.78. Pharmacogenet Genomics. 2005. PMID: 16041242

4

Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population.

Ravn LS, Benn M, Nordestgaard BG, Sethi AA, Agerholm-Larsen B, Jensen GB, Tybjaerg-Hansen A. Ravn LS, et al. Among authors: sethi aa. Pharmacogenet Genomics. 2008 Jun;18(6):525-33. doi: 10.1097/FPC.0b013e3282fce3bd. Pharmacogenet Genomics. 2008. PMID: 18496132

5

Angiotensinogen polymorphisms and elevated blood pressure in the general population: the Copenhagen City Heart Study.

Sethi AA, Nordestgaard BG, Agerholm-Larsen B, Frandsen E, Jensen G, Tybjaerg-Hansen A. Sethi AA, et al. Hypertension. 2001 Mar;37(3):875-81. doi: 10.1161/01.hyp.37.3.875. Hypertension. 2001. PMID: 11244011

6

Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study.

Sethi AA, Tybjaerg-Hansen A, Grønholdt ML, Steffensen R, Schnohr P, Nordestgaard BG. Sethi AA, et al. Ann Intern Med. 2001 May 15;134(10):941-54. doi: 10.7326/0003-4819-134-10-200105150-00008. Ann Intern Med. 2001. PMID: 11352695

7

Nanogen microelectronic chip for large-scale genotyping.

Sethi AA, Tybjaerg-Hansen A, Andersen RV, Nordestgaard BG. Sethi AA, et al. Clin Chem. 2004 Feb;50(2):443-6. doi: 10.1373/clinchem.2003.026047. Clin Chem. 2004. PMID: 14752018 No abstract available.

8

[Six case-control studies from the Osterbro-study (The Copenhagen City Heart Study). Angiotensinogen mutations and risk of myocardial and cerebral ischemia].

Sethi AA, Tybjaerg-Hansen A, Grønhold ML, Steffensen R, Schnohr P, Nordestgaard BG. Sethi AA, et al. Lakartidningen. 2002 May 23;99(21):2392-3. Lakartidningen. 2002. PMID: 12090166 Swedish. No abstract available.

9

Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.

Frikke-Schmidt R, Nordestgaard BG, Stene MC, Sethi AA, Remaley AT, Schnohr P, Grande P, Tybjaerg-Hansen A. Frikke-Schmidt R, et al. Among authors: sethi aa. JAMA. 2008 Jun 4;299(21):2524-32. doi: 10.1001/jama.299.21.2524. JAMA. 2008. PMID: 18523221

10

Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study.

Nordestgaard BG, Kontula K, Benn M, Dahlöf B, de Faire U, Edelman JM, Eliasson E, Fyhrquist F, Hille DA, Ibsen H, Lyle PA, Berg K, Sandberg M, Sethi AA, Wong PH, Os I. Nordestgaard BG, et al. Among authors: sethi aa. Pharmacogenet Genomics. 2010 Feb;20(2):77-85. doi: 10.1097/FPC.0b013e328333f70b. Pharmacogenet Genomics. 2010. PMID: 20065889 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page